Viemed Healthcare Inc (VMD) Stock Price, Quote & News

Company Profile

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and ren...

Industry: Medical Devices

Sector: Healthcare

Phone: 337 504 3802

Website: www.viemed.com

Address:

625 East Kaliste Saloom Road, Lafayette, United States

thinkandpick Jun. 30 at 5:12 PM

$VMD $LABU $IBB $QIPT $XBI Healthcare sector. According to the latest proxy, dirt-cheap Viemed Healthcare (VMD) has high insider ownership. Specifically, VMD's insiders own approximately 7.9 million shares of common stock or 20%, so their interests are fully aligned with shareholders': https://www.globenewswire.com/news-release/2025/05/06/3075054/0/en/Viemed-Executes-Diversification-Strategy-With-26-Million-Acquisition-of-Home-Equipment-Provider-in-Illinois.html

0 · Reply

thinkandpick Jun. 30 at 5:06 PM

$VMD $LABU $IBB $XBI $XLV Healthcare sector: Key excerpt regarding dirt-cheap Viemed Healthcare (VMD) and its business in 2025: "While the macro environment has led to significant volatility in the public markets, we have seen NO IMPACT to date to our business from tariffs or a pullback from providers and payers.":https://www.globenewswire.com/news-release/2025/05/07/3076667/0/en/Viemed-Healthcare-Announces-First-Quarter-2025-Financial-Results.html

0 · Reply

dennismccain Jun. 20 at 12:06 AM

$VMD This is an interesting stock. I’ve been in and out of these shares several times over the last few months. It’s been a nice swing trade. The numbers below actually look great but the company is so small with a market cap of just $260M. Average volume for these shares is only 150K shares per day. That’s not a lot of activity and it could potentially affect the price spread. Fortunately there’s a well defined Darvas Box with limits at $6 and $10. When you look at the current earnings of $.30 and next year’s earnings of $.49, and you put a reasonable 20 multiple on those earnings, you also come up with $6 and $10. That’s comforting. Above that you’ll probably encounter some level of resistance near $12.

0 · Reply

CrayP May. 20 at 10:01 AM

$QIPT Forager likely has no intention of buying but every intention of putting the company in play a it makes sense as a PE-backed roll-up or sale to anther strategic like $VMD. That's not to say they are not serious the top holders (including Forager at roughly 10%) own 3X more than insiders and are at critical mass to help ensure sale to an alternative bidder. Need to read the Kamen standstill though from a little ways back....

0 · Reply

Vern82 May. 16 at 11:39 PM

$VMD https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-viemed-healthcare-vmd

0 · Reply

dennismccain May. 12 at 3:41 PM

$VMD Viemed Healthcare, Inc. recently announced its agreement to acquire Lehan’s Medical Equipment, an Illinois-based provider specializing in home medical equipment for respiratory care and women’s health. Viemed's CEO, Casey Hoyt, emphasized Lehan's strong reputation and commitment to community engagement, which aligns with Viemed's growth strategy in the expanding healthcare market. Lehan, a family-owned business established in 1946, generated approximately $25.7 million in revenue in 2024 and has a dedicated team of over 90 employees. The acquisition, valued at around $26 million, is expected to close in Q3 2025 and will be funded through cash and existing credit facilities. This move diversifies Viemed's product offerings and strengthens its position in the healthcare sector. This acquisition is expected to be completed by the third quarter of 2025. I currently have a very small but growing position in these shares. Options are monthly. https://www.lehansmedical.com

0 · Reply

dennismccain May. 10 at 4:55 AM

$VMD The numbers below look good and the chart speaks for itself. The trading range for swing trades and option sells is identified by the top and bottom of the box. The eventual price target is where the arrow is pointing. The best buy point is always near support. And that’s where we seem to find ourselves this weekend. It looks like if you can get the shares near $6, you’ll eventually have a double on your hands.

3 · Reply

Vern82 May. 10 at 1:20 AM

$VMD

0 · Reply

Pitoentuboca May. 9 at 7:05 PM

$VMD IM IN HERE $1 TRILLION SHARES $$$$$ BUY BUY UP MONDAY

0 · Reply

Vern82 May. 8 at 3:06 PM

$VMD Another great quarter and an aquisiton announcement. Down 9%. Lol. Bought the dip. 9pt.

0 · Reply

Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results

May 10, 2025, 12:15 PM EDT - 2 months ago

Viemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:45 PM EDT - 2 months ago

Viemed Healthcare Announces First Quarter 2025 Financial Results

May 6, 2025, 8:30 AM EDT - 2 months ago

Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

Apr 22, 2025, 4:30 PM EDT - 2 months ago

Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

Apr 20, 2025, 10:13 PM EDT - 2 months ago

Viemed Healthcare: Remaining Bullish Due To Strong Forward-Looking EPS Revisions

Mar 11, 2025, 5:24 PM EDT - 4 months ago

Viemed Healthcare, Inc. (VMD) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 5:00 PM EDT - 4 months ago

Viemed Healthcare Announces Record 2024 Financial Results

Nov 9, 2024, 12:39 PM EST - 8 months ago

Viemed Healthcare, Inc. (VMD) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:45 PM EST - 8 months ago

Viemed Healthcare Announces Third Quarter 2024 Financial Results

Sep 12, 2024, 1:35 AM EDT - 10 months ago

Viemed Healthcare: Turning Bullish Once More On Growing Ventilator Patient Numbers

Aug 8, 2024, 4:53 PM EDT - 11 months ago

Viemed Healthcare, Inc. (VMD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 5:00 PM EDT - 11 months ago

Viemed Healthcare Announces Record Second Quarter 2024 Financial Results

Jul 24, 2024, 9:00 AM EDT - 1 year ago

Viemed Healthcare Announces Date and Time for Conference Call

May 7, 2024, 2:23 PM EDT - 1 year ago

Viemed Healthcare, Inc. (VMD) Q1 2024 Earnings Call Transcript

May 6, 2024, 5:00 PM EDT - 1 year ago

Viemed Healthcare Announces First Quarter 2024 Financial Results

Apr 2, 2024, 9:00 AM EDT - 1 year ago

Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

Mar 7, 2024, 5:07 PM EST - 1 year ago

Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 5:00 PM EST - 1 year ago

Viemed Healthcare Announces Record 2023 Financial Results

Dec 7, 2023, 9:00 AM EST - 1 year ago

Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX

Nov 7, 2023, 9:00 AM EST - 1 year ago

Viemed Healthcare to Present at Stifel 2023 Healthcare Conference

Nov 4, 2023, 1:19 PM EDT - 1 year ago

Viemed Healthcare, Inc. (VMD) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 5:00 PM EDT - 1 year ago

Viemed Healthcare Announces Record Third Quarter 2023 Financial Results

Aug 31, 2023, 9:00 AM EDT - 2 years ago

Viemed Healthcare to Participate in Upcoming Investor Conferences

Aug 15, 2023, 3:36 PM EDT - 2 years ago

Viemed Healthcare: Qualified Growth Company, HMP Transaction Accretive To Value

Aug 9, 2023, 4:15 PM EDT - 2 years ago

Viemed Healthcare Announces Second Quarter 2023 Financial Results

Jun 13, 2023, 5:00 PM EDT - 2 years ago

Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

Jun 1, 2023, 4:05 PM EDT - 2 years ago

Viemed Announces Successful Completion Of HMP Acquisition

May 18, 2023, 2:18 AM EDT - 2 years ago

Viemed Healthcare: Superb Growth Expectations, Reiterate Buy

May 9, 2023, 2:37 PM EDT - 2 years ago

Viemed Healthcare, Inc. (VMD) Q1 2023 Earnings Call Transcript

May 8, 2023, 5:15 PM EDT - 2 years ago

Viemed Healthcare Announces First Quarter 2023 Financial Results

Apr 18, 2023, 9:00 AM EDT - 2 years ago

Viemed Accelerates Growth Through Acquisition of Tennessee Based Home Medical Products, Inc.

Apr 11, 2023, 9:00 AM EDT - 2 years ago

Viemed Healthcare to Present at Bloom Burton & Co. Healthcare Conference

Mar 3, 2023, 12:53 PM EST - 2 years ago

Viemed Healthcare, Inc. (VMD) Q4 2022 Earnings Call Transcript

Mar 2, 2023, 4:45 PM EST - 2 years ago

Viemed Healthcare Announces 2022 Financial Results

Feb 21, 2023, 10:33 PM EST - 2 years ago

Viemed Healthcare: Steady As She Goes

Jan 23, 2023, 9:00 AM EST - 2 years ago

Viemed Wins Complete Overruling of Appealed OIG Claims Resolving Multiyear Process With HHS and CMS

Jan 12, 2023, 9:00 AM EST - 2 years ago

Viemed Announces Strategic Investment in Population Health Sector

Nov 29, 2022, 4:00 PM EST - 2 years ago

Viemed Announces New Senior Secured Credit Facilities

Nov 22, 2022, 3:44 AM EST - 2 years ago

Viemed Healthcare: Revising Case To Buy

Nov 2, 2022, 4:53 PM EDT - 2 years ago

Viemed Healthcare, Inc. (VMD) Q3 2022 Earnings Call Transcript

Nov 1, 2022, 4:30 PM EDT - 2 years ago

Viemed Healthcare Announces Third Quarter 2022 Financial Results

Aug 3, 2022, 8:30 PM EDT - 3 years ago

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q2 2022 Results - Earnings Call Transcript

Aug 2, 2022, 5:20 PM EDT - 3 years ago

Viemed Healthcare Announces Second Quarter 2022 Financial Results

Aug 1, 2022, 9:00 AM EDT - 3 years ago

Viemed Announces Executive Additions to Lead Acquisition Growth

Jul 5, 2022, 4:15 PM EDT - 3 years ago

Viemed Announces Publication of Peer-Reviewed NIVH Study Finding Treatment Reduces Healthcare Costs and Saves Lives

May 26, 2022, 6:15 PM EDT - 3 years ago

Viemed Healthcare to Host Investor Webcast

May 16, 2022, 7:30 AM EDT - 3 years ago

Viemed Provides Update Concerning Successful Appeal of Office of Inspector General Findings

May 8, 2022, 1:11 AM EDT - 3 years ago

Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q1 2022 Results - Earnings Call Transcript

May 3, 2022, 5:00 PM EDT - 3 years ago

Viemed Healthcare Announces First Quarter 2022 Financial Results

thinkandpick Jun. 30 at 5:12 PM

0 · Reply

thinkandpick Jun. 30 at 5:06 PM

0 · Reply

dennismccain Jun. 20 at 12:06 AM

0 · Reply

CrayP May. 20 at 10:01 AM

0 · Reply

Vern82 May. 16 at 11:39 PM

$VMD https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-viemed-healthcare-vmd

0 · Reply

dennismccain May. 12 at 3:41 PM

0 · Reply

dennismccain May. 10 at 4:55 AM

3 · Reply

Vern82 May. 10 at 1:20 AM

$VMD

0 · Reply

Pitoentuboca May. 9 at 7:05 PM

$VMD IM IN HERE $1 TRILLION SHARES $$$$$ BUY BUY UP MONDAY

0 · Reply

Vern82 May. 8 at 3:06 PM

$VMD Another great quarter and an aquisiton announcement. Down 9%. Lol. Bought the dip. 9pt.

0 · Reply

Vern82 Apr. 25 at 9:19 PM

$VMD

0 · Reply

NVDAMillionaire Mar. 26 at 6:31 AM

$VMD VMD looking strong in home respiratory care. Organic growth strategy and strategic acquisitions positioning them well. Ventilator rental revenue showing solid momentum. Watching closely for Q1 performance and potential expansion moves. Bullish on their market positioning. compelling article: https://beyondspx.com/article/viemed-healthcare-inc-a-leader-in-home-respiratory-care-and-medical-equipment-services

0 · Reply

d_risk Mar. 10 at 10:18 PM

$VMD - Viemed Healthcare Inc. Common Shares - 10K - Updated Risk Factors VMD's 2025 risk factors highlight increased competition, reimbursement challenges, supply chain disruptions, cybersecurity threats, and regulatory scrutiny, alongside new operational risks from AI integration and changes in reporting status. #Risk https://d-risk.ai/VMD/10-K/2025-03-10

0 · Reply

DonCorleone77 Mar. 10 at 10:16 PM

$VMD Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M Sees FY25 adjusted EBITDA $54M-$58M.

0 · Reply

DonCorleone77 Mar. 10 at 10:15 PM

$VMD Viemed Healthcare reports Q4 EPS 10c vs 9c last year Reports Q4 revenue $60.7M, two estimates $59.4M. Casey Hoyt, Viemed's CEO, noted, "We once again demonstrated our value as a vital link between patients, providers, and payers for complex respiratory services with fourth quarter results meeting the high end of our expectations and maintaining a track record of strong organic growth and profitability, while at the same time enhancing the balance sheet. The sequential improvement in our operational metrics throughout 2024 reinforces the momentum we have established with hard-won improvements in our sales force and diversification of the business. Likewise, the continued demand for our high-touch, technology-enabled clinical approach in a regulatory environment that stresses efficiency, home care, transparency, and compliance gives us greater confidence in our value proposition."

0 · Reply

Doozio Jan. 26 at 3:42 PM

$VMD .75 down or yo INTA 🧠⏰♾️

0 · Reply

Walley_1950 Jan. 3 at 11:41 AM

$VMD management to is a joke. The higher ups take no responsibility for the staff in the field that “actually work” $2.00 in my opinion

0 · Reply

LoneBroker Dec. 13 at 3:56 PM

$VMD failed, so exited 😢

0 · Reply

LoneBroker Dec. 12 at 6:30 AM

$VMD let’s go up 🥳

0 · Reply

NVDAMillionaire Nov. 25 at 1:11 AM

$VMD Viemed Healthcare (VMD): A Beacon of Innovation in Respiratory Care https://beyondspx.com/article/viemed-healthcare-vmd-a-beacon-of-innovation-in-respiratory-care

0 · Reply

kno420 Nov. 11 at 5:59 PM

$VMD Gap, crap, and gap again after ER. Strong results that should get continue to improve especially if a beneficiary of tax cuts.

0 · Reply

d_risk Nov. 6 at 10:31 PM

$VMD - 10Q - New Risk Factors https://d-risk.ai/VMD/10-Q/2024-11-06

0 · Reply

Market Cap	282.60M
Revenue (ttm)	224.26M
Net Income (ttm)	11.27M
EPS (ttm)	N/A
PE Ratio	23.60
Forward PE	N/A
Profit Margin	5.03%
Debt to Equity Ratio	0.03

Volume	107,453
Avg Vol	190,652
Day's Range	N/A - N/A
Shares Out	39.52M
Stochastic %K	86%
Beta	1.37
Analysts	Strong Sell
Price Target	$15.00